Lopez Fabio 4
4 · SELLAS Life Sciences Group, Inc. · Filed Sep 26, 2018
Insider Transaction Report
Form 4
Lopez Fabio
Director10% Owner
Transactions
- Other
Common Stock
2018-09-24−1,521,863→ 0 total - Other
Common Stock
2018-09-24−676,324→ 0 total - Other
Common Stock
2018-09-24−325,799→ 0 total
Footnotes (6)
- [F1]EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund ("Sely S") distributed 1,521,863 shares to its partners on a pro rata basis, for no consideration.
- [F2]As a partner of Sely S, Fabio Lopez, received 19,524 of the shares distributed by Sely S.
- [F3]EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund ("Sely I") distributed 676,324 shares to its partners on a pro rata basis, for no consideration.
- [F4]As partners of Sely I, Daniel Tafur and Equilibria Capital Management received 13,871 and 107,619, respectively, of the shares distributed by Sely I.
- [F5]EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund ("Sely II") distributed 325,799 shares to its partners on a pro rata basis, for no consideration.
- [F6]As partners of Sely II, Fabio Lopez and Daniel Tafur received 6,325 and 2,372, respectively, of the shares distributed by Sely II.